NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc (the "Company" or "Evome") highlighted the strengthening credit relationship with Pathward, N.A. ("Pathward"), the Company's senior lender. As the Company works to sell non-core business units to reduce acquisition debt in an effort to improve operational profitability, Pathward provides working capital to fuel revenue growth of the Company's new Biodex products. Pathward has featured the strong and growing relationship with Evome as an example of its willingness to fund growth companies:
Evome Medical Technologies enjoys multi-year expansion with financing from Pathward
Web link:
https://www.pathward.com/news/evome-medical-technologies-enjoys-multi-year-expansion-with-fina/
This focus on revenue growth and market expansion has led the Company's operating subsidiary, ? Biodex Rehab Systems, LLC ("Biodex"), to launch a new, high-tech product called the RST (Reactive Step Trainer), previously announced by the Company. The RST was launched by the Company at the American Physical Therapy Association Combined Sections Meeting in Boston on February 15, 2024. The RST is designed to improve balance and reduce tripping and falling, particularly among elderly patients. The Reactive Step Trainer can provide repetitive conditioning training along with random and on-demand perturbation challenges, designed to help patients improve their compensatory step strategies and reduce fall risk. It has been meticulously engineered to be cost-effective, ensuring accessibility to a wider range of patients, while also prioritizing functionality to effectively cater to the clinical requirements of Physical Therapists.
Looking ahead, Evome plans to continue its innovation with the upcoming launch of the SpaceTek Knee. This isokinetic device, co-developed with NASA, represents another milestone in Evome's commitment to advancing medical technology and improving patient outcomes while improving margins and increasing sales by democratizing its technology to a broader market.
"As we focus on the higher margin Biodex product line, we will work towards shedding non-core assets for the purpose of reducing existing acquisition debt," said CEO Mike Seckler. "Simbex was an excellent example of this strategy. By selling Simbex, we both paid down a significant portion of acquisition debt and we are able to focus our time, capital and energy on the Biodex product line."
The Company also announced that the non-binding letter of intent (LOI) to extend acquisition debt related to the Company's acquisition of Simbex LLC in 2021, previously announced by the Company on February 8, 2024, has been cancelled and the unsecured and subordinated debt will revert to its previous status as an unsecured subordinated debt of the Company.
Mike Seckler ?
Chief Executive Officer ?
Tel: 1 (800) 760-6826 ?
Email: Info@Salonaglobal.com?
Cautionary Statements
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the ?policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this ?release.?
Certain statements contained in this press release constitute "forward-looking information" within ?the meaning of the Private Securities Litigation Reform Act of 1995 and applicable Canadian securities ?laws. These statements can be identified by the use of forward-looking terminology such as "expects" ??"believes", "estimates", "may", "would", "could", ??"should", "potential", ?????"will", "seek", "intend", ??"plan", and "anticipate", and similar expressions as they relate ????to the Company, including: ?the Company reducing debt by divesting non-core business units and the financial implications of such divestitures; the benefits of using the RST; and the Company launching its SpaceTek Knee product toward the end of the year. All ?statements ?other than statements of ??historical fact may be forward-looking? information. Such statements reflect the Company's current ?views and intentions with respect to future ?events, and current information available to the Company, ?and are subject to certain risks, ?uncertainties and assumptions, including: the Company successfully identifying a buyer for a non-core business and negotiating and closing a sale; the Company having the necessary capital to complete its business objectives. The Company cautions that the forward-looking statements contained ?herein are qualified by important factors that could cause actual results to differ materially from ?those reflected by such statements. Such factors include but are not limited to the ??general business ?and ??economic ?conditions in the regions in ?which the Company operates; the ability of the Company to ?execute on key ??priorities, ?including the successful completion of acquisitions, business? retention, and?? ?strategic plans and to?? attract, develop ?and retain key executives; difficulty integrating newly acquired ?businesses; ??ongoing or new disruptions in the supply chain, the extent and scope of such supply chain ?disruptions, and the timing or extent of the resolution or improvement of such disruptions; the ability ?to??? implement business strategies and pursue business opportunities; ??disruptions in or attacks ??(including ?cyber-attacks) on the Company's information technology, internet, network access or other ???voice or data ?communications systems or services; the evolution of various types of fraud or other ????criminal behavior to which ? the Company is exposed; the failure of third parties to comply with their ?obligations to ?? the Company or its ?affiliates; the? impact of new and changes to, or application of, ?current laws and regulations; ?granting of permits and licenses in a highly regulated business; the ??overall difficult ?????litigation environment, including in the United States; increased competition; changes ?in foreign currency rates; ?increased ????funding ?costs and market volatility due to market illiquidity and ?competition for funding; the ?availability of funds ????and resources to pursue operations; critical ??accounting estimates and changes to accounting standards, policies,???? and methods used by the ?Company; the occurrence of natural and unnatural?? catastrophic ?events ?and claims ????resulting from such ?events; as well as those risk factors discussed or ?referred to ?in the ?Company's disclosure ?documents ?filed with United States Securities and Exchange Commission ?and ?available at ?www.sec.gov, and with ??the securities regulatory authorities in certain provinces of Canada and ??available at ??www.sedarplus.ca. Should any ?factor affect the Company in an unexpected manner, or should ???assumptions underlying ?the forward-looking ?information prove incorrect, the actual results or events ?may differ ??materially from the results ?or events predicted. ?Any such forward-looking information is ?expressly qualified in its ??entirety by this cautionary ?statement. Moreover, ?the Company does not ?assume responsibility for the accuracy or ??completeness of such ?forward-looking ?information. The ?forward-looking information included in this press release ??is made as of the ?date of this press ?release ?and the Company undertakes no obligation to publicly update or revise ??any forward-?looking ?information, ?other than as required by applicable law?.?
